BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 33112109)

  • 1. Review on significance of GDNF, PTCH1 and RNF213 in chromophobe renal cell carcinoma illustrated by the case of 71-years-old man.
    Kowalik A; Wincewicz A; Ossoliński K; Zięba S; Kopczyński J; Ossoliński T; Góźdź S; Koda M; Sulkowski S
    Pol J Pathol; 2020; 71(3):195-199. PubMed ID: 33112109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Next-Generation Sequencing to Detect Deletion of RB1 and ERBB4 Genes in Chromophobe Renal Cell Carcinoma: A Potential Role in Distinguishing Chromophobe Renal Cell Carcinoma from Renal Oncocytoma.
    Liu Q; Cornejo KM; Cheng L; Hutchinson L; Wang M; Zhang S; Tomaszewicz K; Cosar EF; Woda BA; Jiang Z
    Am J Pathol; 2018 Apr; 188(4):846-852. PubMed ID: 29353061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular and Genomic Profiling to Identify Actionable Targets in Chromophobe Renal Cell Cancer.
    Abbosh P; Sundararajan S; Millis SZ; Hauben A; Reddy S; Geynisman DM; Uzzo R
    Eur Urol Focus; 2018 Dec; 4(6):969-971. PubMed ID: 28753842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of mutation of the folliculin gene in sporadic chromophobe renal cell carcinoma and renal oncocytoma.
    Nagy A; Zoubakov D; Stupar Z; Kovacs G
    Int J Cancer; 2004 Apr; 109(3):472-5. PubMed ID: 14961590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in the von Hippel-Lindau (VHL) gene refine differential diagnostic criteria in renal cell carcinoma.
    Barnabas N; Amin MB; Pindolia K; Nanavati R; Amin MB; Worsham MJ
    J Surg Oncol; 2002 May; 80(1):52-60. PubMed ID: 11967908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VHL gene alterations in renal cell carcinoma patients: novel hotspot or founder mutations and linkage disequilibrium.
    Ma X; Yang K; Lindblad P; Egevad L; Hemminki K
    Oncogene; 2001 Aug; 20(38):5393-400. PubMed ID: 11536052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VHL alterations in human clear cell renal cell carcinoma: association with advanced tumor stage and a novel hot spot mutation.
    Brauch H; Weirich G; Brieger J; Glavac D; Rödl H; Eichinger M; Feurer M; Weidt E; Puranakanitstha C; Neuhaus C; Pomer S; Brenner W; Schirmacher P; Störkel S; Rotter M; Masera A; Gugeler N; Decker HJ
    Cancer Res; 2000 Apr; 60(7):1942-8. PubMed ID: 10766184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The genetic basis of cancer of the kidney.
    Linehan WM; Walther MM; Zbar B
    J Urol; 2003 Dec; 170(6 Pt 1):2163-72. PubMed ID: 14634372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromophobe Renal Cell Carcinoma With Retrograde Venous Invasion and Gain of Chromosome 21: Potential Harbingers of Aggressive Clinical Behavior.
    Jamal M; Taneja K; Arora S; Barod R; Rogers CG; Sanchez J; Gupta NS; Williamson SR
    Int J Surg Pathol; 2018 Sep; 26(6):536-541. PubMed ID: 29560759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noncoding RNA Expression and Targeted Next-Generation Sequencing Distinguish Tubulocystic Renal Cell Carcinoma (TC-RCC) from Other Renal Neoplasms.
    Lawrie CH; Armesto M; Fernandez-Mercado M; Arestín M; Manterola L; Goicoechea I; Larrea E; Caffarel MM; Araujo AM; Sole C; Sperga M; Alvarado-Cabrero I; Michal M; Hes O; López JI
    J Mol Diagn; 2018 Jan; 20(1):34-45. PubMed ID: 29056573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in BHD and TP53 genes, but not in HNF1beta gene, in a large series of sporadic chromophobe renal cell carcinoma.
    Gad S; Lefèvre SH; Khoo SK; Giraud S; Vieillefond A; Vasiliu V; Ferlicot S; Molinié V; Denoux Y; Thiounn N; Chrétien Y; Méjean A; Zerbib M; Benoît G; Hervé JM; Allègre G; Bressac-de Paillerets B; Teh BT; Richard S
    Br J Cancer; 2007 Jan; 96(2):336-40. PubMed ID: 17133269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pVHL-associated SCF ubiquitin ligase complex: molecular genetic analysis of elongin B and C, Rbx1 and HIF-1alpha in renal cell carcinoma.
    Clifford SC; Astuti D; Hooper L; Maxwell PH; Ratcliffe PJ; Maher ER
    Oncogene; 2001 Aug; 20(36):5067-74. PubMed ID: 11526493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal cell carcinoma development in the rat independent of alterations at the VHL gene locus.
    Walker C; Ahn YT; Everitt J; Yuan X
    Mol Carcinog; 1996 Feb; 15(2):154-61. PubMed ID: 8599582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of atherosclerotic-moyamoya syndrome with genetic variant of RNF213 p.R4810K and p.T1727M: A case report.
    Liu Y; Wu X; Fan Z; Cheng J; Zhong L; Lin Y; Qu X
    Clin Neurol Neurosurg; 2018 May; 168():163-166. PubMed ID: 29567577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chromophobe cell renal carcinoma: a case report].
    Aihara K; Ikeda R; Satoh H; Kawamura K; Miyazawa K; Suzuki K
    Hinyokika Kiyo; 2000 Jan; 46(1):19-22. PubMed ID: 10723659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allelic loss at 10q23.3 but lack of mutation of PTEN/MMAC1 in chromophobe renal cell carcinoma.
    Sükösd F; Digon B; Fischer J; Pietsch T; Kovacs G
    Cancer Genet Cytogenet; 2001 Jul; 128(2):161-3. PubMed ID: 11463457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rare and Low-Frequency Variants in RNF213 Confer Susceptibility to Moyamoya Syndrome Associated with Hyperthyroidism.
    Nomura S; Akagawa H; Yamaguchi K; Ishikawa T; Kawashima A; Kasuya H; Mukawa M; Nariai T; Maehara T; Okada Y; Kawamata T
    World Neurosurg; 2019 Jul; 127():e460-e466. PubMed ID: 30922903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a splice-site mutation in the tumor suppressor gene FLCN associated with renal cancer.
    Bartram MP; Mishra T; Reintjes N; Fabretti F; Gharbi H; Adam AC; Göbel H; Franke M; Schermer B; Haneder S; Benzing T; Beck BB; Müller RU
    BMC Med Genet; 2017 May; 18(1):53. PubMed ID: 28499369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of mutations of PARP1, RNF213, PAX8, KMT2C, MTRR in malignant mesothelioma of testicular tunica vaginalis testis.
    Kowalik A; Wincewicz A; Zięba S; Baran W; Kopczyński J; Koda M; Sulkowski S; Goźdź S
    Pol J Pathol; 2020; 71(1):69-74. PubMed ID: 32429658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted exome sequencing and chromosomal microarray for the molecular diagnosis of nevoid basal cell carcinoma syndrome.
    Matsudate Y; Naruto T; Hayashi Y; Minami M; Tohyama M; Yokota K; Yamada D; Imoto I; Kubo Y
    J Dermatol Sci; 2017 Jun; 86(3):206-211. PubMed ID: 28342698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.